Nuvation Bio Inc.
€4.115
EUR
Last updated on --.
24h volume2.47M
24h highest4.3220 EUR
24h lowest4.0304 EUR
24h Price movement+2.03%
NUVB recent prices
24 Hours
+2.03%+€0.08171
30 days
+9.10%+€0.35694
60 days
+22.84%+€0.79559
90 days
-15.82%-€0.80419
Key data
Previous close4.0339 EUR
Market cap1.35B EUR
Volume2.47M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.36124 EUR
Net income (FY)-125.57M EUR
Revenue (FY)123.03M EUR
Last report dateMay 4, 2026
About Nuvation Bio Inc.
HeadquartersNEW YORK
Employees (FY)307.00
Revenue per employee (FY)400.76K EUR
Net income per employee (FY)-409.02K EUR
Listed onNew York Stock Exchange
NUVB conversion tables
 |  |
|---|---|
| 0.5 NUVB | 2.057 EUR |
| 1 NUVB | 4.115 EUR |
| 5 NUVB | 20.57 EUR |
| 10 NUVB | 41.15 EUR |
| |
|---|---|
| 0.5 EUR | 0.12149 NUVB |
| 1 EUR | 0.24298 NUVB |
| 5 EUR | 1.214 NUVB |
| 10 EUR | 2.429 NUVB |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
NUVB is trading at €4.115, +2.03% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NUVB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NUVB is currently trading at €4.115, +2.03% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NUVB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NUVB's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NUVB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NUVB's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Nuvation Bio Inc.'s market cap is currently 1.35B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.47M
24h highest4.3220 EUR
24h lowest4.0304 EUR
24h Price movement+2.03%
Start trade with NUVB Perpetual
Sign up to trade